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ARTICLE
Structural basis for adhesion G protein-coupled
receptor Gpr126 function
Katherine Leon1,2, Rebecca L. Cunningham3, Joshua A. Riback1,4, Ezra Feldman1, Jingxian Li1,2, Tobin R. Sosnick1,5,
Minglei Zhao1, Kelly R. Monk3,6 & Demet Araç 1,2*
Many drugs target the extracellular regions (ECRs) of cell-surface receptors. The large and
alternatively-spliced ECRs of adhesion G protein-coupled receptors (aGPCRs) have key
functions in diverse biological processes including neurodevelopment, embryogenesis, and
tumorigenesis. However, their structures and mechanisms of action remain unclear, ham-
pering drug development. The aGPCR Gpr126/Adgrg6 regulates Schwann cell myelination,
ear canal formation, and heart development; and GPR126mutations cause myelination defects
in human. Here, we determine the structure of the complete zebraﬁsh Gpr126 ECR and reveal
ﬁve domains including a previously unknown domain. Strikingly, the Gpr126 ECR adopts a
closed conformation that is stabilized by an alternatively spliced linker and a conserved
calcium-binding site. Alternative splicing regulates ECR conformation and receptor signaling,
while mutagenesis of the calcium-binding site abolishes Gpr126 function in vivo. These
results demonstrate that Gpr126 ECR utilizes a multi-faceted dynamic approach to regulate
receptor function and provide relevant insights for ECR-targeted drug design.
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Multicellular organisms rely on cellular communicationto carry out critical biological processes, and numerouscell-surface receptors utilize their extracellular regions
(ECRs) to modulate these cellular-adhesion and signaling events.
For example, the ECRs of integrins, epidermal growth factor
receptor (EGFR), and several G protein-coupled receptors
(GPCRs) change conformation upon ligand binding, which pro-
pagates signals across the membrane1–9. Targeting the essential
ECRs of receptors with antibody-like drugs to trap the ECRs in
distinct conformations, or to modulate ECR-ligand interactions
has been an effective way to treat diseases caused by defective
proteins. Currently, the anti-cancer drug cetuximab targets EGFR
to prevent an activating extended ECR conformation10, and the
drug etrolizumab blocks ligand binding to the ECRs of integrins
in order to treat inﬂammatory bowel diseases11. Remarkably,
earlier this year, the migraine preventive drug erenumab, which
blocks ligand binding to the ECR of calcitonin receptor-like
receptor, became the ﬁrst antibody drug against a GPCR to be
approved by the Food and Drug Administration12,13. Despite
these and other breakthroughs, there are many essential receptors
in the human genome that are not currently drugged, including
the 32 adhesion GPCRs (aGPCRs), a diverse and understudied
family of GPCRs with critical roles in synapse formation, angio-
genesis, neutrophil activation, embryogenesis, and more14–16.
Like all GPCRs, aGPCRs have canonical signaling seven-
transmembrane (7TM) domains17,18. However, unlike most other
GPCRs, aGPCRs have large ECRs, which can extend up to almost
6000 amino acids (aa) and consist of various adhesion domains
that mediate cell–cell and cell–matrix interactions19. In addition,
during biosynthesis, aGPCRs are uniquely autoproteolysed within
a conserved GPCR Autoproteolysis INducing (GAIN) domain of
the ECR that is juxtaposed to the 7TM20, resulting in a fractured
receptor that nevertheless remains tightly associated at the cell
surface21,22.
Although their protein architectures remain largely unknown,
functional studies have shown that aGPCR ECRs can regulate
receptor function and that antibody-like synthetic proteins that
target the ECRs can modulate downstream signaling9,22–25. A
current model for aGPCR regulation suggests that transient
interactions between the ECR and 7TM directly regulate receptor
signaling9,22–25. There are also numerous reports that aGPCRs
use their ECRs to mediate functions in a 7TM-independent
manner26–30. Another non-mutually exclusive model for aGPCR
activation posits that ligand binding to the ECR can exert force
and cause dissociation at the autoproteolysis site, revealing a
tethered peptide agonist, which then activates the receptor31–34.
Clearly, the ECRs of aGPCRs have signiﬁcant and diverse roles
but remain poorly understood at a molecular level due to the
scarcity of structural information, such as interdomain interac-
tions, protein architecture, and identities of extracellular domains,
which would provide insight into their mechanisms of action.
Gpr126/Adgrg6 is one of the better studied aGPCRs and is
essential for Schwann cell (SC) myelination and other func-
tions35–37. In vertebrate peripheral nervous system (PNS) devel-
opment, the myelin sheath surrounding axons is formed by SCs
and functions to facilitate rapid propagation of action poten-
tials38. Disruption of myelination is associated with disorders
such as Charcot-Marie-Tooth disease, which is characterized by
muscle weakness39,40. In gpr126-mutant zebraﬁsh, SCs fail to
express genes critical for myelination during development and are
not able to myelinate axons due to deﬁcient G-protein signaling.
Additional studies have shown that this regulatory function of
Gpr126 is conserved in mammals41,42 and that Gpr126 also plays
a role in myelin maintenance through communication with the
cellular prion protein43. In humans, GPR126 mutations are linked
to several cancers and other diseases44–48, including adolescent
idiopathic scoliosis49 and arthrogryposis multiplex congenita, a
disorder characterized by multiple joint contractures50. Further-
more, Gpr126 is required for inner ear development in zebra-
ﬁsh35 and GPR126 is required for heart development in mouse37,
and it has been shown that the latter function is ECR-dependent
and does not require the 7TM30. While the biological signiﬁcance
of Gpr126 has become indisputable over recent years, the mole-
cular mechanisms underlying Gpr126 functions remain unclear.
Gpr126 has a large ECR consisting of 839 aa. Prior to the
current study, four domains in the ECR of Gpr126 had been
identiﬁed through sequence-based bioinformatics: Complement
C1r/C1s, Uegf, Bmp1 (CUB), Pentraxin (PTX), Hormone
Receptor (HormR), and GAIN20,51,52. However, a 150 aa region
between PTX and HormR, could not be assigned to a known
structural fold. Furin, a Golgi-localized protease, is reported to
cleave human and mouse GPR126 in this region51, although any
effect on protein architecture is unclear because of the unspeciﬁed
structure. In addition, alternative splicing occurs in
Gpr126/GPR126, resulting in Gpr126/GPR126 isoforms that vary
in their ECRs51,53. Alternative splicing of exon 6 was observed in
human and zebraﬁsh30,51, producing isoforms that either include
(S1 isoform, henceforth referred to as +ss) or exclude (S2 iso-
form, henceforth referred to as −ss) a 23 aa segment found within
the unknown region between PTX and HormR. A genetic variant
in GPR126 leading to decreased inclusion of exon 6 was recently
found to be associated with adolescent idiopathic scoliosis54.
Thus, determining the ECR structure, conformation, and other
possible unexplored features will be instrumental in under-
standing Gpr126 function.
In this study, we determine the high-resolution crystal struc-
ture of the full-length ECR of zebraﬁsh Gpr126, which reveals ﬁve
domains, including a newly identiﬁed Sperm protein, Enter-
okinase and Agrin (SEA) domain, in which furin-mediated
cleavage would occur in the human and mouse homologs.
Intriguingly, the ECR is in an unexpected closed conformation
that is reminiscent of the inactive closed conformation of the
ECRs from EGFR and integrin families. This closed conformation
is sustained by an alternatively spliced linker, while insertion of
the alternatively spliced site gives rise to dynamic open-like ECR
conformations and increases downstream signaling. A second
feature that also mediates the closed conformation is a newly
identiﬁed calcium-binding site at the tip of the ECR. Strikingly,
zebraﬁsh carrying point mutations at this site have both myeli-
nation defects and malformed ears, demonstrating the critical role
of the ECR in Gpr126 function in vivo. These results altogether
show that the ECR of Gpr126 has multifaceted roles in regulating
receptor function, a feature that is likely true for other aGPCRs,
and that will form the basis for further investigations in the efforts
to drug aGPCRs.
Results
Structure of the full-length ECR of Gpr126. To determine the
structure of the ECR of Gpr126, the full-length ECR (−ss) from
zebraﬁsh Gpr126 (T39-S837) was expressed and puriﬁed from
insect cells using the baculovirus expression system. Zebraﬁsh
Gpr126 (Fig. 1a) has high sequence identity (47%) to its human
homolog but its ECR has a fewer number of N-linked glycosy-
lation sites (15 predicted in zebraﬁsh, 26 in human) and no furin-
cleavage site (Supplementary Fig. 1A), and thus yields a more
homogeneous sample (Supplementary Fig. 1B, C). Crystals of
both native and selenomethionine (SeMet)-labeled zebraﬁsh
Gpr126 ECR (−ss) were obtained and diffracted to 2.4 Å (Sup-
plementary Fig. 1D), and the structure was determined by SeMet
single-wavelength anomalous diffraction (SAD) phasing (Sup-
plementary Table 1).
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The structure, with overall dimensions of 110 × 80 × 35 Å,
revealed the presence of ﬁve domains (Fig. 1b, c), of which only
four were identiﬁed previously. The N-terminal region of the
protein is composed of the CUB domain followed very closely by
the PTX domain. The 150 aa unknown region after the PTX
domain was revealed to be a 22 aa linker that is partially
disordered, the 23 aa alternatively spliced region (not present in
crystal structure construct), and a structured domain which spans
105 aa and was identiﬁed as a SEA domain through the Dali
server55. The Gpr126 SEA domain adopts a ferredoxin-like alpha/
beta sandwich fold, common to SEA domains from other
proteins. Interestingly, analysis of the structure as well as
sequence alignments between zebraﬁsh and human showed that
furin cleavage in humans would occur in the SEA domain
(Supplementary Fig. 1A). Finally, the SEA domain is followed by
the HormR and GAIN domains, the latter of which is
autoproteolyzed as expected (Supplementary Fig. 1E). The
HormR and GAIN domain structures are similar to previously-
solved HormR+GAIN domain structures from other
aGPCRs9,20, with the exception of the relative orientation
between HormR and GAIN. There is a 90° rotation of the
HormR domain with respect to the GAIN domain (Supplemen-
tary Fig. 1F) in Gpr126 compared to previously-solved HormR+
GAIN structures from rLphn1 and hBAI320. In addition, Gpr126
was observed to have at least ten sites of glycosylation throughout
all domains of the ECR except the PTX domain (Fig. 1b).
Gpr126 (−ss) ECR adopts a closed conformation. Unexpect-
edly, the structure revealed a compact, closed conformation
where the most N-terminal CUB domain interacts with the more
C-terminal HormR and GAIN domains (Fig. 1b). To ensure that
this conformation is not a crystallization artifact, we utilized both
negative-stain electron microscopy (EM) and small-angle X-ray
scattering (SAXS) to conﬁrm that the closed conﬁrmation is
observed for Gpr126 in solution. Negative-stain 2D class averages
of Gpr126 ECR showed a V-shaped protein architecture (Fig. 1d).
The individual domains in the 2D class averages were assigned
according to size and are consistent with the closed architecture
of the crystal structure. In addition, we measured the radius of
gyration (Rg) of the ECR using SAXS to conﬁrm that the closed
conformation exists in solution. The observed Rg (41.1 ± 0.1 Å) is
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Fig. 1 Crystal structure of the full extracellular region of Gpr126. a Domain organization of Gpr126, indicating the ECR and 7TM regions. The unknown
region includes a splice site. Cleavage sites (furin cleavage, autoproteolysis) are indicated by dashed lines. Domains are colored dark blue (CUB), cyan
(PTX), gray (unknown region), yellow (HormR), red (GAIN), and purple (7TM). Domain boundaries are indicated below. SP indicates signal peptide. b
Structure of the full ECR of (−ss) Gpr126. Domains are colored as in a except for the newly identiﬁed SEA domain (green). Domains are numbered (1–5)
from N to C-terminus. Calcium ion in CUB domain is indicated as a green sphere. Dashed lines represent disordered residues. N-linked glycans are shown
as green sticks. c Schematic of full-length Gpr126. The previously unknown region (SEA domain and linker region) is labeled. Autoproteolysis in GAIN
domain is indicated by an asterisk and the last beta-strand of the GAIN domain is colored gray. d Representative negative-stain EM 2D class average of
Gpr126 (−ss) ECR. Scale bar (white) represents 50 Å. Domains are assigned and colored according to color scheme noted above. The dashed line
represents the linker region.
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consistent with the calculated Rg of the closed-conformation
crystal structure model (42.6 Å) and inconsistent with that of an
extended model of Gpr126 ECR in which the CUB domain points
away, rather than toward, the center of the molecule (Rg= 52.2 Å)
(Supplementary Fig. 1G). Taken together, these results: show that
Gpr126 ECR is in a closed conformation in solution, demonstrate
that this conformation is not an artifact of crystal-packing con-
tacts, and suggest that this closed conformation may play an
important role in Gpr126 function.
As the closed conformation of Gpr126 (−ss) ECR was shown
to exist both in solution and in the crystal lattice, we next wanted
to explore the interactions that contribute to this protein
architecture. Close examination of the crystal structure revealed
two interaction sites that mediate the closed conformation, the
ﬁrst of which is a direct interaction between domains that are at
opposite ends of the ECR and the second is an indirect interaction
formed between two domains through a loop that holds them
together (Fig. 2a).
First, a direct interaction exists at the tip of the CUB domain
(close to the N-terminus), which points inward towards the
center of the molecule and lies in the interface between GAIN and
HormR. Residues in the HormR domain (H516, F533, P534,
Y535) interact with each other through pi-pi stacking (sandwich),
promoting interaction with F135 on the CUB domain through
additional (T-shaped) pi-pi stacking to stabilize the CUB-HormR
interaction (Fig. 2b).
Surprisingly, examination of the 2Fo-Fc electron density map
showed that there is density within the CUB domain at this
interface that does not belong to any amino acid residue
(Supplementary Fig. 2A). This density is coordinated by the
side-chain groups of E89, D97 (bidentate) and D134, main-chain
carbonyl groups of S136 and V137, as well as a water molecule for
a complex with coordination number 7 in a pentagonal
bipyramid geometry (Fig. 2c). The geometry and distances
between the density and the coordinating residues in Gpr126
are consistent with calcium coordination56. Several CUB domains
from extracellular proteins are reported to coordinate calcium,
including Gpr12657, and some have been discovered to use this
coordination to mediate ligand binding57–61 (Supplementary
Fig. 2B). For example, the C1s protein uses its CUB calcium-
binding site to bind to ligand C1q and initiate the classical
pathway of complement activation61, and the Lujo virus
recognizes a calcium-binding site on the CUB domain of the
neurophilin-2 receptor in order to gain cell entry59. The calcium-
coordinating residues are all conserved in the Gpr126 CUB
domain (among GPR126 proteins from various species (Fig. 2d)
as well as among calcium-binding CUB domains from other
proteins (Supplementary Fig. 2C)), suggesting that the density is
indeed calcium. Importantly, the calcium coordination aligns the
coordinating residues E89 and D134 on the surface of the CUB
domain such that they can interact with K536 on the HormR
domain (Fig. 2c), contributing to the closed conformation.
In addition to the direct CUB-HormR interaction, a second
interaction site is formed by a disulﬁde-stabilized loop, which
provides a bridge between the CUB and HormR domains.
Although 13 (C355-A367) of the 22 aa (C355-P376) in the linker
Coordinates Ca2+ (side chain group) 
Hydrophobic residue in CUB-HormR interface


















































Fig. 2 Closed conformation of Gpr126 is mediated by CUB-HormR-linker interactions. a Structure of the full ECR of (−ss) Gpr126. b Close-up view of the
CUB-HormR interface. Resides at the interface are shown as sticks. The calcium ion is shown as a bright green sphere. c Close-up view of the calcium-
coordination site within CUB domain. The water molecule is shown as a blue sphere. The residues are shown as sticks. CUB residues are colored dark blue
and HormR residue is colored yellow. Residue labels are colored according to their roles in CUB-HormR interaction: red (E89, D97, D134) represents
calcium coordination by side-chain residue, blue (S136, V137) represents calcium coordination by main-chain carbonyl group, purple (F135) represents a
hydrophobic residue in CUB-HormR interface, and orange (Y61) represents a residue that stabilizes calcium-coordinating residue D97. Calcium
coordination is shown as bright green dashed lines. CUB-HormR interaction is shown as yellow dashed lines. The interaction between Y61 and D97 is
shown as a magenta dashed line. d Sequence alignment of partial Gpr126 CUB domain from various species, highlighting important conserved residues:
calcium-coordinating residues by side-chain group (red), calcium-coordinating residues by main-chain carbonyl (blue), a tyrosine residue that stabilizes a
calcium-coordinating residue (orange), and a hydrophobic phenylalanine residue in the CUB-HormR interface (purple). e Close-up view of the disulﬁde-
stabilized loop inserted between CUB and HormR domains. The disulﬁde bond is colored bright orange and is indicated by an arrow. The dashed line
represents disordered residues in the linker region.
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region are disordered in the structure, the rest were able to be
resolved and they form a small loop stabilized by a disulﬁde bond
between C369 and C375 (Fig. 2e). This loop is located directly N-
terminal to the SEA domain and is inserted between the CUB and
HormR domains, effectively bridging the two domains and likely
contributing to the stabilization of the closed conformation. The
cysteines that form the disulﬁde bond are conserved among all
except four of the 94 species analyzed in this study (Supplemen-
tary Fig. 2D and Supplementary Data 1), suggesting that this
disulﬁde bond plays an important role in Gpr126 function. The
ﬁve residues (ASGLG) ﬂanked by the cysteines are small and
ﬂexible, accommodating the formation of the disulﬁde loop as
well as insertion into the small pocket between CUB and HormR.
Alternative splicing modulates Gpr126 ECR conformation.
Gpr126 is alternatively spliced, producing several isoforms that
may modulate protein function. Skipping of exon 6 results in
deletion of 23 aa in zebraﬁsh (28 aa in human) and is of particular
interest because these amino acids reside in the previously
unknown region of Gpr126 ECR. The 23 aa region is rich in
serine/threonine residues (10 out of 23) and contains a predicted
N-linked glycosylation site, which suggests that this region may
be a highly O- and N-link glycosylated stalk. From analysis of the
crystal structure (−ss isoform, in which the 23 aa are deleted), we
determined that the splice site is directly between the regions
encoding the disulﬁde-stabilized loop and the SEA domain
(Fig. 3a). Because the disulﬁde-stabilized loop makes contacts that
are important for the closed conformation of Gpr126 ECR (−ss)
(Fig. 2e), we hypothesized that the (+ss) isoform would disrupt
the closed conformation and have a different, more open
conformation.
To test whether Gpr126 ECR (+ss) and (−ss) have different
conformations, the two proteins were puriﬁed and analyzed using
negative-stain EM. Single particles were classiﬁed into 2D class
averages and the class averages were further categorized into
groups to facilitate interpretation of different conformations. The
class averages for the (−ss) isoform, categorized into ﬁve main
orientations (Fig. 3b), were consistent with the closed conforma-
tion of the crystal structure (Fig. 1b). However, the class averages
for the (+ss) isoform (Fig. 3c) showed a diverse population of
ECR molecules, as they contain additional more open-like
conformations (group vi, 21% of particles, Fig. 3d) as well as
closed conformations that were observed in the (−ss) isoform
(Fig. 3c, d). Furthermore, individual (+ss) particles showed the
presence of open conformations (Fig. 3e), including a fully
extended conformation, which could not be classiﬁed into a
distinct class average during image processing. These results are
consistent with our hypothesis that the (+ss) ECR conformation
is different from that of (−ss) and suggest that the addition of 23
aa extends the linker in (+ss), likely disrupting the indirect and
direct CUB-HormR interactions and preventing the stable closed
conformation that is observed in (−ss) (Fig. 3f).
The negative-stain EM data are consistent with SAXS
experiments showing that the Rg of zebraﬁsh Gpr126 ECR
(+ss) is larger than that of (−ss) with a more dramatic change in
Rg observed between the human GPR126 isoforms (Supplemen-
tary Fig. 3A-F and Supplementary Table 2). Size-exclusion
chromatography elution proﬁles for both zebraﬁsh and human
constructs also showed that (+ss) elutes earlier compared to
(−ss), indicative of a larger size and different shape (Supple-
mentary Fig. 3G, H).
Alternative splicing modulates Gpr126 receptor signaling. To
determine whether the two isoforms also exhibit different levels
of signaling, receptor activity was measured for both isoforms
using a G protein signaling assay. Human GPR126 has been
shown previously to couple to and activate Gαs, leading to pro-
duction of cAMP42. Therefore, we used a cAMP signaling assay in
which HEK293 cells were co-transfected with a full-length zeb-
raﬁsh Gpr126 construct and a reporter luciferase that emits light
upon binding to cAMP. Cell-surface expression levels of the
constructs were quantiﬁed by ﬂow cytometry analysis of cells
stained by antibodies against N-terminal FLAG-tags (Fig. 4a and
Supplementary Fig. 4A, B, C), and basal signaling results (Fig. 4b)
were normalized to expression level (Fig. 4c).
Cells transfected with either (−ss) or (+ss) Gpr126 had higher
cAMP levels compared to cells transfected with an empty vector
(EV) (Fig. 4c), demonstrating that basal activity of Gpr126 can be
detected in this assay. As a positive control, a synthetic peptide
agonist that targets the 7TM activated zebraﬁsh Gpr126 and
human GPR126 signaling to a level consistent with similar,
previously-published experiments on human GPR12632 (Supple-
mentary Fig. 4D) and did not activate signaling in EV-
transfected cells.
However, the closed-conformation (−ss) Gpr126 signaled
signiﬁcantly less compared to the more dynamic (+ss) Gpr126
(Fig. 4c), and this result was consistent between both zebraﬁsh
and human constructs (Supplementary Fig. 4C and Fig. 4d–f).
This suggests that the additional amino acids in the linker region
of the ECR as a result of alternative splicing plays a role in
modulating the activity of Gpr126 and that the ECR of Gpr126 is
coupled to receptor signaling. Taken together with the negative-
stain EM results, the (−ss) and (+ss) Gpr126 isoforms are
distinct in terms of ECR conformation dynamics, as well as G
protein signaling activity.
In addition, we mutated calcium-binding site residues D134A/
F135A in the (−ss) isoform, which we predicted would disrupt
the closed conformation. Using negative-stain EM, we observed
open ECR conformations for this construct (Supplementary
Fig. 4E-G), similar to the wild-type (+ss) isoform (Fig. 3c and
Supplementary Fig. 4H). The calcium-binding site mutation did
not increase or decrease the cAMP signaling for the (−ss) Gpr126
isoform, which suggests that the ECR conformation is not solely
responsible for regulation of receptor signaling. However, the
same mutation in the (+ss) isoform resulted in lower cAMP
levels compared to wild-type (+ss) (Supplementary Fig. 4I). Cell-
surface expression levels of these mutant Gpr126 constructs in
HEK293 cells were similar or higher than wild-type constructs,
excluding the possibility that lower signaling was due to improper
protein folding or trafﬁcking (Supplementary Fig. 4I). Altogether,
these results might be explained by a complex, rather than a
simple and straightforward, model of regulation for receptor
signaling and suggest a possible functional role for the calcium-
binding site.
Calcium-binding site is critical for PNS myelination in vivo.
Functional sites on proteins are usually highly evolutionarily con-
served. We used the ConSurf server62 to perform surface con-
servation analyses on a diverse set of 94 Gpr126 protein sequences.
The conservation score for each residue was mapped onto the
Gpr126 ECR structure (Supplementary Fig. 5A), which revealed
that the most conserved domain in the ECR is the CUB domain.
Importantly, the calcium-binding site is absolutely the most highly
conserved patch within the CUB domain and within the entire
Gpr126 ECR (Fig. 5a). The calcium-binding site is universally
conserved among all species analyzed, which suggests that the
calcium-binding site has an essential role in Gpr126 function.
We next wanted to test whether the residues in the calcium-
binding site are important for Gpr126 function in vivo. Gpr126
has previously been shown to regulate both PNS myelination and
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ear development in zebraﬁsh through elevation of cAMP35,36.
Zebraﬁsh gpr126 mutations that impair G protein signaling result
in abolished myelination of the peripheral axons by SC and cause
“puffy” ears28,32,35,36,63. GPR126 has been shown to have a role in
heart development in mouse37, supported by additional studies in
zebraﬁsh28,30,63. Gpr126 activity in zebraﬁsh can be readily
measured by analyzing the expression of myelin basic protein
(mbp), which encodes a major structural component of the
myelin sheath and is essential for PNS myelination, and by
assessing ear and heart morphologies of the ﬁsh. To determine
whether the calcium-binding site is important for these functions,
two amino acids in the site, D134 and F135, were targeted and
mutated to alanines using CRISPR/Cas9-mediated homologous
recombination. D134 directly coordinates the calcium ion and
F135 is an adjacent hydrophobic residue which forms one arm of
the calcium-binding pocket (Figs. 2c, 5a). As a result, the mutant
zebraﬁsh, gpr126stl464, harbor D134A and F135A mutations
(Fig. 5b, Supplementary Fig. 5B). These mutations created a
BstUI restriction enzyme site, which was used to genotype
individual zebraﬁsh (Fig. 5c). Expression of gpr126 is unaffected
in gpr126stl464 mutants (Supplementary Fig. 5C, D). Strikingly,
compared to wild-type siblings, the gpr126stl464-mutant zebraﬁsh
developed the puffy ears (Fig. 5d, e) that are indicative of a defect
in Gpr126-mediated G protein signaling, though they do not
appear to have heart defects (Supplementary Fig. 5E-T). In
addition to the ear phenotype, mutant zebraﬁsh did not express
mbp, indicative of failed PNS myelination (Fig. 5f, g, Supple-
mentary Fig. 5U, V). These results show that D134 and F135 in
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Fig. 3 Alternative splice isoforms of Gpr126 modulate ECR conformation. a Schematic diagram of Gpr126 splice isoforms generated by including (+ss) or
excluding (−ss) exon 6. Residues encoded by exon 6 are colored magenta. Gray asterisks indicate potential O-linked glycosylation sites and the black
asterisk indicates a predicted N-linked glycosylation site. The conserved disulﬁde bond in the linker is colored yellow. b, c Negative-stain EM 2D class
averages for −ss (b) and +ss (c) ECR constructs. Class averages are categorized according to similar orientations: (i, ii, iii, iv, v, and vi). (i, ii, iii, iv) are
observed in both –ss and +ss isoforms. (vi) represents open-like conformations (>50° angle) that are observed only in the +ss isoform. (v) represents
unidentiﬁable miscellaneous views. Scale bars (white) represent 50 Å. d Quantiﬁcation of percentage of particles per category for both isoforms.
e Representative individual particles for both isoforms. Yellow arrows point to particles which are not in a closed conformation. f ECR conformations based
on negative-stain EM are depicted as cartoons. The splice site is shown in magenta. Black arrows with dashed lines indicate dynamic ECR conformation.
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Identiﬁcation of a proteolytic SEA domain in human GPR126.
As mentioned earlier, the previously unknown region in the
Gpr126 ECR contains a structured domain, which we revealed to
be a SEA domain (Fig. 6a). Gpr126 SEA superimposes well over
known SEA domains from Mucin-1 and Notch-264,65, which are
cleaved (via autoproteolysis and furin, respectively), both in the
same loop between beta-strand 2 and beta-strand 3 (Fig. 6b, c).
Although the GPR126 furin-cleavage site is conserved in many
mammals and birds (Supplementary Data 1, Supplementary
Fig. 1A), with a consensus sequence of (R/K)-X-K-R↓, it is not
conserved in zebraﬁsh Gpr126. Using sequence alignments
(Fig. 6d) and homology modeling, we mapped the furin-cleavage
site in human GPR126 (Fig. 6e, Supplementary Fig. 6A) to the
same loop that is cleaved in Mucin-1 and Notch-2, suggesting
that SEA domain cleavage plays similar roles in each of these


























































































































































































Fig. 4 Alternative splice isoforms of Gpr126 modulate receptor signaling. a Cell-surface expression levels for empty vector (EV), zebraﬁsh Gpr126 splice
isoforms, measured using ﬂow cytometry to detect binding of anti-FLAG antibody to cells expressing FLAG-tagged Gpr126. The Gpr126 cell-surface
expression levels are normalized to the control EV signal. Data are shown as MFI (mean ﬂuorescence intensity). Error bars are not shown because
expression levels are presented as median ﬂuorescence intensities of 10,000 cells for each population of transfected cells, for a single ﬂow cytometry
experiment representative of at least three independent experiments. b Basal signaling measured by the cAMP signaling assay. Data are shown as fold
increase over EV of RLU (relative luminescence units). c Basal cAMP signaling normalized to cell-surface expression. ns, P > 0.05; *P≤ 0.05; **P≤ 0.01;
***P≤ 0.001; ****P≤ 0.0001; by one-way ANOVA and Tukey’s multiple comparisons test. Data in b and c are presented as mean ± SEM, n= 3, and are
representative of at least three independent experiments. d–f Same as a–c but for human GPR126 splice isoforms. Source data are provided as a Source
Data ﬁle.
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abolish furin cleavage in both human GPR126 (−ss) and (+ss)
isoforms (Supplementary Fig. 6B, C). In addition, these mutant
GPR126 constructs were transfected into HEK293 cells and were
detected on the cell surface (Supplementary Fig. 6D), and
therefore, the importance of furin cleavage is likely not primarily
important for proper expression and trafﬁcking.
To our knowledge, SEA and GAIN are the only known protein
domains that are proteolyzed and remain associated even after
proteolysis. In proteins like Mucins and Notch, the cleaved SEA
domain remains intact65,66 and shear forces likely unfold the
domain and separate the protein into two fragments67,68. The
Gpr126 SEA domain shows several noncovalent interdomain
interactions, particularly between all four of the beta-strands that
form a beta-sheet (Fig. 6f). The separation of the human GPR126
furin-cleaved SEA domain into two fragments does not readily
occur immediately following cleavage as the cleaved protein
resists separation when puriﬁed by size-exclusion
chromatography (Supplementary Fig. 6B), similar to the afore-
mentioned SEA domains as well as to GAIN domain autopro-
teolysis. Instead, the two fragments likely stay associated
noncovalently until a disruptive event, such as ligand binding
and mechanical force, unfolds the SEA domain and leads to
separation or shedding of the region N-terminal to the furin-
cleavage site (CUB, PTX, linker, half of SEA) and the C-terminal
region (half of SEA, HormR, GAIN, 7TM).
Discussion
aGPCRs make up the second largest family of GPCRs with 32
members in humans and are essential for numerous biological
processes such as synapse formation, cortex development, neu-
trophil activation, angiogenesis, embryogenesis, and many more.
Recent studies have shown that the ECRs of aGPCRs play
important roles in these functions; however, the relative lack of
information about the structures of ECRs and their mechanisms
of activation hampers further studies toward drugging these
receptors. Here we show that the large ECR of Gpr126, an aGPCR
with critical functions in PNS myelination, ear development, and
heart development, adopts an unexpected closed conformation
where the most N-terminal CUB domain interacts with the more
C-terminal HormR domain. The structure of the Gpr126 ECR
revealed that the closed conformation is mediated through a
calcium-binding site as well as a disulﬁde-stabilized loop. Inter-
estingly, the residues involved in these intramolecular interactions
are highly conserved among Gpr126 sequences, including that of
zebraﬁsh, raising questions about their role in Gpr126 function.
Alternative splicing is a mechanism to increase the functional
diversity of metazoan genomes and has been repeatedly demon-
strated to play a role in the regulation of brain function. For
example, alternative splicing contributes to the functional diver-
siﬁcation of DSCAMs, protocadherins, calcium channels, neur-
exins, and neuroligins69–72. It is also proposed that alternative
splicing may cause a large conformational change in the ECR of
the synaptic protein teneurin, since alternative splicing allows the
protein to act as a switch in regulating ligand binding despite the
ligand-binding site being distant from the seven aa alternatively
spliced site73. Since gpr126 is alternatively spliced in the region
encoding the ECR, we examined the functional differences
between isoforms. Our negative-stain EM and SAXS results
suggest that alternative splicing between the regions encoding the
PTX and SEA domains in gpr126 perturbs the closed con-
formation and generates a population of ECR conformations that
range from closed to extended (Fig. 7a). Several of the inserted
residues resulting from alternative splicing are predicted to be
sites of glycosylation. These glycosylation sites as well as the state
of the other glycosylation sites may contribute to the change in
ECR conformation. Our signaling assay results also show that
alternative splicing leads to changes in basal receptor activity,
which suggests that the architecture and conformation of aGPCR
ECRs play more important roles in their functions than pre-
viously thought. However, the signaling assay results showing
that the change of Gpr126 ECR conformation is not solely
responsible for changes in signaling may be confusing and con-
tradictory. Rather, a more complex model that combines changes
in ECR conformation with exposure of potential functional sites
due to these changes may be key for alternative splicing-mediated
regulation.
Importantly, we identiﬁed the calcium-binding site in Gpr126
as a potential functional site. Our in vivo results showed that
zebraﬁsh carrying two point-mutations in the calcium-binding
site have defective SC and ear development, suggesting that the
calcium-binding site is essential for the in vivo functions of


















Fig. 5 The calcium-binding site is required for Gpr126 function in vivo. a
Surface conservation analysis (green, variable; purple, conserved) of CUB
domain. The calcium-binding site is circled in magenta. D134 and F135 are
indicated by arrows. b D134 and F135 were both mutated to alanines
through homologous recombination of a 150 bp ssODN containing a 5 bp
mutation (red nucleotides). c Genotyping assay for the gpr126stl464
lesion. The 5 bp mutation introduces a BstUI restriction enzyme binding
site. d 4 dpf wild-type larva compared to e 4 dpf gpr126stl464/stl464 larva
with puffy ears (arrowheads). Scale bars (black) represent 100 μm. f 4 dpf
wild-type larvae express mbp throughout the posterior lateral line nerve
(PLLn, arrowhead), whereas g 4 dpf gpr126stl464/stl464 larva lack mbp
expression along the PLLn (arrowhead). Scale bars (black) represent 100
μm. Asterisks indicate CNS.
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proteins coordinate calcium in order to mediate ligand-binding57,
one possibility for the critical function of the calcium-binding site
in Gpr126 may be to act as a ligand-binding site as well, although
future experiments will need to be performed to validate this
hypothesis.
The structure also revealed the presence of a SEA domain. In
human and other species, a furin-cleavage site is mapped to this
domain but this cleavage site is not conserved in zebraﬁsh.
Therefore, the function of the furin-cleavage may play a role in
GPR126 that is not conserved in zebraﬁsh. Cleaved SEA domains
from other proteins have been shown to stay intact until a force is
applied and pulls apart the fragments67,68. Similarly, GPR126
may regulate its activity by furin-dependent shedding in addition
to the established GAIN-autoproteolysis-dependent shedding.
Moreover, the released extracellular fragments may act as diffu-
sible ligands and bind to other cell-surface receptors, but further
studies need to be done to test this model. Other aGPCRs that
have SEA domains in their ECRs include ADGRF1/GPR110 and
ADGRF5/GPR11674,75. Although these SEA domains are not
cleaved by furin, they do contain the GSVVV (or GSIVA) motif
that leads to autoproteolytic cleavage in the same loop (between
beta-strand 2 and beta-strand 3) that is cleaved by furin in
GPR126. Therefore, SEA domain cleavage, whether by autopro-
teolysis or by furin, is a common feature in several aGPCRs and
may have similar roles in regulating receptor function.
Taken together, our results suggest that Gpr126 is a complex
protein that makes use of its many domains to regulate its
function. In addition to the autoproteolysis-dependent activation
mechanism (Supplementary Fig. 7A), Gpr126 uses other
mechanisms to regulate its function including modulation of the
ECR conformation. In the closed conformation, Gpr126 signals
less compared to when the ECR is in a more dynamic, open
conformation, which may be regulated by alternative splicing

































Fig. 6 Identiﬁcation of a proteolytic SEA domain in human GPR126. a Crystal structure of the SEA domain from zebraﬁsh Gpr126. b (left) NMR structure
of Mucin-1 SEA domain (PDB: 2ACM) and (right) Gpr126 SEA domain superimposed over Mucin-1 SEA domain. The loop containing the autoproteolysis
site in Mucin-1 is indicated by a yellow arrow. The root-mean-square deviation (RMSD) of atoms between overlaid structures is 2.761 Å. c (left) Crystal
structure of the Notch2 SEA domain (PDB: 2OO4) and (right) Gpr126 SEA domain superimposed over Notch2 SEA domain. The loop containing the furin-
cleavage site (deleted in crystal structure construct) is indicated by an orange arrow. The RMSD of atoms between overlaid structures is 4.767 Å.
d Sequence alignment of partial SEA domain from human Mucin-1, human Notch2, human GPR126, and zebraﬁsh Gpr126. e Homology model of human
GPR126 SEA model generated using SWISSMODEL. The arrow points to modelled furin-cleavage site. f Protein topology map of SEA domain. Furin-
cleavage site is indicated by red scissors. Residues N-terminal to cleavage site are dark blue and residues C-terminal to cleavage site are light blue. Dashed
lines represent backbone hydrogen bonds between beta sheets.
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may also regulate receptor function (Supplementary Fig. 7B).
Mutation of the calcium-binding site leads to signaling defects
in vitro and to ear and PNS defects in vivo (Fig. 7b)). In addition,
furin cleavage may allow GPR126 another mode of activation that
is common to other receptors and adhesion GPCRs.
The Gpr126 closed conformation and hidden calcium-binding
site is conceptually similar to EGFR. EGFR is in a closed, compact
inactive conformation until ligand binding leads to a conforma-
tional change that extends the protein and reveals a hidden
functional site that is important for its activation10,76. Because
this mechanism is key for drugging EGFR, the conceptual simi-
larity provides an opportunity to also drug Gpr126. Drugs that
alter the ECR conformation of Gpr126 or block functional sites,
such as the calcium-binding site, may be useful for treating
Gpr126-associated diseases. The ECRs of other aGPCRs are
major players in mediating receptor functions as well. For
example, using its ECR, ADGRA2/GPR124 regulates isoform-
speciﬁc Wnt signaling77–80, the C. elegans ADGRL1/LAT-1
controls cell division planes during embryogenesis, and
ADGRB1/BAI1 and ADGRL3/Lphn3 mediate synapse formation
through interaction with other cell-surface proteins81–84. Thus,
the ECRs of other aGPCR family members are also promising
drug targets to treat numerous diseases once mechanistic details
about their regulatory functions are understood.
Methods
Cloning and puriﬁcation of Gpr126/GPR126 from insect cells. The ECRs
(residues T39-S837) of zebraﬁsh Gpr126 and ECRs (residues C38-A853) of human
GPR126, along with C-terminal 8XHis-tags, were cloned into the pAcGP67a
vector. The following primers were used for ampliﬁcation of zebraﬁsh Gpr126: F:
5’-CGCATTCTGCCTTTGCGGCGAGCACCAGCTGCAATGTGGT-3’ and R: 5’-
GAATTCTAGAAGGTACCCGGTTAGTGGTGGTGATGGTGATGATGATGA
GCTCTAGAGACATCCATTAGGATGCC-3’. The following primers were used
for ampliﬁcation of human GPR126: F: 5’-TCTGCCTTTGCGGCGAGCACCA
GCTGTAGGGTTGTCCTGAGCAACCCG-3’ and R: 5’-GTGGTGGTGATGGTG
ATGATGATGGGACCGTGGCAGATCCATAAGCAC-3’. Human GPR126
R468A mutant ECRs were generated using the QuikChange method (Agilent) with
primers: F: 5’-GACAAGATTAAGGTGAAGGCGTCTTTGGAGGACGAGCC-3’
and R: 5’-GGCTCGTCCTCCAAAGACGCCTTCACCTTAATCTTGTC-3’.
All proteins were expressed using the baculovirus method. Sf9 cells (Thermo
Fisher, 12659017) were co-transfected with the constructed plasmid and linearized
baculovirus DNA (Expression Systems, 91-002) using Cellfectin II (Thermo Fisher,
10362100). Baculovirus was ampliﬁed in Sf9 cells in SF-900 III medium
supplemented with 10% FBS (Sigma–Aldrich, F0926). High Five cells (Thermo
Fisher, B85502) at a density of 2.0 × 106 cells ml−1 in Insect-XPRESS medium
(Lonza, 12-730Q) were infected with high-titer baculovirus and incubated for 72 h
at 27 °C. All subsequent steps are conducted at 25 °C. The cells were pelleted at
900 × g for 15 min and the conditioned medium containing the secreted
glycosylated proteins were collected. To the medium were added ﬁnal
concentrations of 50 mM Tris pH 8, 5 mM CaCl2, and 1 mM NiCl2. The mixture
was stirred for 30 min and then centrifuged at 8000 × g for 30 min. The clariﬁed
supernatant was incubated with nickel-nitrilotriacetic agarose resin (Qiagen,
30250) for 3 h. The resin was collected with a glass Buchner funnel and washed
with HBS buffer (10 mM HEPES pH 7.2, 150 mM NaCl) containing 20 mM
imidazole. Puriﬁed protein was eluted with HBS buffer containing 200 mM
imidazole and run on size-exclusion chromatography (Superdex 200 10/300 GL;
GE Healthcare) in HBS buffer.
Selenomethione-labeled Gpr126 (−ss) ECR was expressed as previously
described85. Brieﬂy, High Five cells in Insect-XPRESS medium were adapted to
ESF921 medium (Expression Systems, 96-001-01). The cells were subsequently
centrifuged at 100 × g for 15 min and resuspended in ESF921 methionine-free
medium (Expression Systems, 96-200). The cells were expanded in the same
medium and then infected at a density of 2.0 × 106 cells ml−1 with high-titer
baculovirus. At 10 h post-infection, 100 mg Seleno-L-methionine (Sigma–Aldrich,
S3132) was added to each liter of cell culture. At 36 h post-infection, another 150
mg Seleno-L-methionine was added to each liter of cell culture. The cells were
harvested 72 h post-infection and the puriﬁcation process was the same as
described above.
X-ray crystallography. Puriﬁed Gpr126 (−ss) ECR (both native and SeMet-
labeled) was crystallized at 3 mgmL−1 in 50 mM potassium dihydrogen phosphate,
20% (w/v) PEG 8000. Both native and SeMet-labeled datasets were collected to 2.4
Å at the Advanced Photon Source at Argonne National Laboratory (beamline 23-
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Fig. 7 Model for ECR-dependent functions of Gpr126. The model depicts how Gpr126/GPR126 function is regulated by its ECR. a Alternative splicing acts
as a molecular switch to adopt different ECR conformations and have different basal levels of signaling. Gpr126 ECR that lacks the splice insert adopts a
closed conformation and has basal activity, whereas Gpr126 ECR that includes the splice insert (magenta) is more dynamic and open-like, and has
enhanced basal activity. Autoproteolysis in GAIN domain is indicated by a black asterisk. The calcium ion is shown as a bright green circle. b Mutation of
conserved residues within the calcium-binding site leads to defects in both myelination and ear development in vivo. Human GPR126 function may also be
regulated by furin cleavage, indicated by a green asterisk.
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determined by SAD phasing using Crank2 in CCP4. Reﬁnement was performed
with both REFMAC5 (CCP4) and phenix.reﬁne (PHENIX).
Negative-stain electron microscopy. Uranyl formate (0.75%) solution was freshly
prepared by adding 5 mL boiling water to 37.5 mg uranyl formate (Electron
Microscopy sciences, 22450). After stirring for 5 min in the dark, 10 μL 5M NaOH
was added and stirred for an additional 5 min. The solution was syringe ﬁltered
(Millipore, SLGV033RS) and stored in the dark. Puriﬁed Gpr126 (−ss), (+ss), and
(−ss) D134A/F135A ECR constructs were diluted to ~5 ug mL−1 and applied to
glow-discharged EM grids (Electron Microscopy Sciences, CF400-Cu,) using a
conventional negative-stain protocol86. To the grid was applied 2 μL diluted pro-
tein for 30 sec. The protein was blotted off with ﬁlter paper (Sigma–Aldrich,
WHA1001110), and then the grid was touched to a 25 μL drop of distilled, ﬁltered
water. The water was blotted off, and the grid was touched to a second 25 μL drop
of water and blotted off. The grid was then touched to a 25 μL drop of 0.75% uranyl
formate for 30 sec and blotted off. The grid was air-dried for 30 sec. The sample
was imaged on a Tecnai G2 F30 operated at 300 kV. Gpr126 −ss (6565 particles),
+ss (2529 particles), and −ss D134A/F135A (3916 particles) were processed using
EMAN287.
Small-angle X-ray scattering. SAXS measurements were performed at the
Advanced Photon Source at Argonne National Laboratory (beamline 18-ID) with
an in-line SEC columns (Superdex 200 or Biorad EnRich 5–650 10–300) equili-
brated with 20 mM HEPES, pH 7.4, and 150 mM NaCl. Data were analyzed using
autorg and datgnom using the commands “autorg –sminrg 0.55 –smaxrg 1.1” and
“datgnom ‘1’.dat -r ‘2’ – skip ‘3’ -o ‘1’.out,” respectively, where ‘1’ is the ﬁle name,
‘2’ is the Rg determined by autorg, and ‘3’ is the number of points removed at low q
as determined from autorg. SAXS curves of molecular models were generated with
Crysol version 2.8388.
cAMP signaling assay. Full-length wild-type and mutant Gpr126/GPR126 con-
structs were cloned into pCMV5. All constructs include N-terminal FLAG-tags for
measuring cell-surface expression levels. The following primers were used for
ampliﬁcation of zebraﬁsh Gpr126: F: 5’-GCTGACTACAAAGACGATGACGACA
AGCTTTGCAATGTGGTGCTCACCGACTCCCAGGGC-3’ and R: 5’-CCTGGCC
AGGCCTCTGGTCCATGAGGCCCCTTATTGCAGGGTACTATCTGCATTACT
GTG-3’. The following primers were used for ampliﬁcation of human GPR126: F:
5’-GCTGACTACAAAGACGATGACGACAAGCTTTGCGCAAACTGTAGGGT
TGTCCTGA-3’ and R: 5’-CAGGCCTCTGGTCCATGAGGCCCCTCAACAGGG
GCCAGTTTTCACCAG-3’. Zebraﬁsh Gpr126 D134A/F135A mutant constructs




HEK293 cells (ATCC CRL-1573) were seeded in 6-well plates with Dulbecco’s
Modiﬁed Eagle Medium (DMEM; Gibco, 11965092) supplemented with 10% FBS
(Sigma–Aldrich, F0926). At 60–70% conﬂuency, the cells were co-transfected with
0.35 μg Gpr126 DNA, 0.35 μg GloSensor reporter plasmid (Promega, E2301), and
2.8 μL transfection reagent Fugene 6 (Promega, PRE2693). After a 24-h incubation,
the transfected cells were detached and seeded (50,000 cells per well) in a white 96-
well assay plate. Following another 24-h incubation, the DMEM was replaced with
100 μL Opti-MEM (Gibco, 31985079) and incubated for 30 min. To each well was
then added 1 μL GloSensor substrate and 11 μL FBS. Basal-level luminescence
measurements were taken after 30 min to allow for equilibration. For activation
assays, the cells were then treated with either 1 mM p14 synthetic peptide
(GenScript, N-THFGVLMDLPRSASEKEK-Biotin-C) or vehicle DMSO for 15 min.
Measurements were taken with a Synergy HTX BioTeck plate reader at 25 °C.
Flow cytometry to measure cell-surface expression of Gpr126. HEK293 cells
were transfected as described above and incubated for 24 h. The cells were then
detached and seeded in a 24-well plate. Following another 24-h incubation, the cells
were detached with citric saline and washed with phosphate-buffered saline (PBS).
The cells were then washed twice with PBS supplemented with 0.1% BSA
(Sigma–Aldrich, A3803). The cells were incubated with mouse anti-FLAG primary
antibody (1:1000 dilution in PBS+ 0.1% BSA; Sigma–Aldrich, F3165) at room
temperature for 30 min and washed twice with PBS+ 0.1% BSA. The cells were
then incubated with donkey anti-mouse Alexa Fluor 488 secondary antibody (1:500
dilution in PBS+ 0.1% BSA; Invitrogen, A21202) at room temperature for 30 min
and washed twice with PBS+ 0.1% BSA. Stained cells were resuspended in PBS+
0.1% BSA and were analyzed with a BD Accuri C6 ﬂow cytometer.
Zebraﬁsh rearing. Zebraﬁsh were maintained in the Washington University
Zebraﬁsh Consortium Facility (http://zebraﬁsh.wustl.edu), and the following
experiments were performed according to Washington University animal proto-
cols. All zebraﬁsh experiments were performed in compliance with institutional
ethical regulations for animal testing and research at Washington University and
Oregon Health and Science University (OHSU). Experiments were approved by the
Animal Care and Use Committee of Washington University School of Medicine
(St. Louis, MO) and the Institutional Care and Use Committee of OHSU (Portland,
OR). The gpr126stl464 zebraﬁsh were generated within the wild-type AB* back-
ground. All crosses were either set up as pairs or harems and embryos were raised
at 28.5 °C in egg water (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM
MgSO4). Larvae were staged at days post fertilization (dpf). gpr126stl464 larvae can
be identiﬁed at 4 dpf by a puffy ear phenotype.
Genotyping. To identify carriers of the gpr126stl464 allele, the following primers
were used to amplify the 381 base pair (bp) locus of interest: F: 5’-GTTGTCG
TCAAGACCGGCAC-3’ and R: 5’- TCCACCTCCCAGCTACAATTCC-3’. After
ampliﬁcation by PCR, the product was digested with either DrdI (NEB) at 37 °C or
BstUI (NEB) at 60 °C, and then run on a 3% agarose gel. The mutation both
disrupts a DrdI binding site and introduces a BstUI binding site. DrdI cleaves wild-
type PCR product into 275 and 105 bp products, and the mutant product is 380 bp.
BstUI cleaves mutant PCR product into 274 and 106 bp products, and the wild-
type product is 380 bp. We recommend using BstUI for genotyping. Any larvae
identiﬁed with the puffy ear phenotype were always genotyped as gpr126stl464
homozygous mutant (n= 20/20).
Guide RNA synthesis. Potential gRNA templates were generated by CHOPCHOP
(http://chopchop.cbu.uib.no/). The chosen forward and reverse oligonucleotides,
20 bps upstream of the PAM sequence, were ordered with additional nucleotides
added to the 5’ end to permit cloning into the pDR274 vector89. The oligonu-
cleotide forward sequence used was: 5’ - tag gAC TTT AGT GTC CAA AAG
AA - 3’ and oligonucleotide reverse sequence used was: 5’- aaa cTT CTT TTG GAC
ACT AAA GT – 3’. 2 uM of each oligonucleotide was mixed in annealing buffer
(10 mM Tris, pH 8, 50 mM NaCl, 1 mM EDTA) and incubated at 90 °C for 5 min,
then cooled to 25 °C over a 45 min time interval. The pDR274 vector was linearized
with BsaI and oligonucleotides were ligated into the vector with T4 ligase (NEB) for
10 min at room temperature. The ligation reaction was transformed into competent
cells and then plated on kanamycin LB plates. Selected colonies were grown, mini-
prepped (Zyppy Plasmid Kits, Zymo Research), and Sanger sequenced. The gRNA
DNA sequence was then PCR ampliﬁed from 50 ng μL−1 of the plasmid with
Phusion (NEB) and the following primers: F: 5’-GTTGGAACCTCTTACGT
GCC-3’ and R: 5’-AAAAGCACCGACTCGGTG-3’. The PCR product was digested
with DpnI at 37 °C for 1 h, heat inactivated at 80 °C for 20 min, and then puriﬁed
with a Qiagen PCR Puriﬁcation column. RNA was synthesized with a MEGAscript
T7 Transcription Kit (Ambion).
Design of ssODN and microinjections. One-cell stage wild-type embryos were
injected with either 2 or 3 nl of a solution containing ~132 ng μL−1 gRNA, ~148 ng
μL−1 of Cas9 mRNA (obtained from the Hope Center Transgenic Core at
Washington University in St. Louis), and 60 ng μL−1 of the ssODN. The 150 bp
ssODN was ordered from IDT and contained a 5 bp mutation (uppercase): 5’-atcat
aaacatacccttgcttgtaactgatatggaagcctttcttttggacactCGCCGcggagttaaagaaaacctccatcac
atttccagtggagttgag-3’. Please note that an extra C (bolded), beginning after exon 3,
is present in the ssODN that is not present in the gpr126 reference sequence. The
extra nucleotide was not integrated into the stl464 mutants. At 1 dpf, embryos were
genotyped for disruption of the wild-type DrdI binding site and screened for the
characteristic gpr126 puffy ear mutant phenotype. Mutations that were successfully
transmitted to the F1 offspring were screened for by restriction enzyme digest
analysis. Mutant bands were gel extracted (Qiagen Gel Extraction Kit) and Sanger
sequenced to identify the incorporation of the ssODN containing the mutation of
interest.
Whole mount in situ hybridization. 1 dpf larvae were treated with 0.003% phe-
nylthiourea to inhibit pigmentation until ﬁxation in 4% paraformaldehyde at 4 dpf.
After ﬁxation, larvae pooled in microcentrifuge tubes were dehydrated in methanol
(5 by 5 min washes while nutating) and then stored at −20 °C. To begin in situ
hybridization, larvae were re-hydrated with 50, 70, and 100% 0.2% PBS-Tween:
methanol (5 min washes on a nutator). PBS-Tween washes were then continued (4
by 5 min washes while nutating). Larvae were then treated with 1:900 Proteinase-K
(20 mg/mL) in PBS-Tween for 45 min at room temperature (not on a nutator).
After Proteinase-K treatment, two quick PBS-Tween washes were performed, and
then larvae were post-ﬁxed in 4% paraformaldehyde for 20 min while nutating.
Larvae were then washed with PBS-Tween (5 by 5 min washes on a nutator) and
then incubated in hybridization buffer (Hyb(+)) at 65 °C for at least 1 h in a dry
heat block. The riboprobe of interest in Hyb(+) was then incubated with the larvae
overnight at 65 °C in a dry heat block. The following day, larvae were washed in
100% Hyb(+), 75% Hyb(+): 25% 2X SSCTween, 50% Hyb(+): 50% 2X SSCTween,
25% Hyb(+): 75% 2X SSCTween, all preheated to 65 °C, in a dry heat block. Larvae
were then washed with 2X SSCTween (two washes, 30 min each) and 0.2X
SSCTween (two washes, 30 min each) at 65 °C in a dry heat block. Larvae were then
washed with MAB-TritonX-100 for 10 min at room temperature while nutating
and then blocked in blocking solution (2% blocking reagent in MAB+ 0.2% Tri-
tonX-100+ 10% sheep serum) for at least 1 h at room temperature on a nutator.
Larvae were then treated with anti-DIG AP Fab fragments (1:2000 – Roche
11093274910) in blocking solution overnight at 4 °C on a nutator. The following
day, larvae were washed with MAB-TritonX-100 (6 by 30 min washes on a nutator)
at room temperature. After a 10 min wash in alkaline phosphatase/NTMT (AP)
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buffer, larvae were moved to a 24-well plate, covered in aluminum foil to prevent
light exposure, and incubated with NBT (2.2 µL mL−1)+ BCIP (1.6 µL mL−1) in
AP buffer until the reaction completed. After development of the probe, larvae
were washed with three quick PBS-Tween washes and then passed through 30, 50,
and 70% glycerol washes. A complete protocol with detailed notes is available90.
The previously characterized riboprobes utilized in this study were mbp (GenBank:
AY860977.1)91, and gpr126, originally synthesized with 5’- ggaattcgtgatggagctggt-
gaacatagc-3’ and 5’-agtgtcgactcacttctcatctatcaactcagcagc-3’ primers36. For mbp,
larvae were scored for either presence or absence of signal expression along
the PLLn.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The accession number for the coordinates and diffraction data for the Gpr126 (−ss) ECR
crystal structure reported in this paper is PDB: 6V55. The SASBDB IDs for the SAXS
experimental data are: SASDFT9, SASDFU9, SDSDFV9, SASDFW9, SASDFX9. The
source data underlying Fig. 4b, c, e, f and Supplementary Figures 1B, 4C, H, and 6B, C are
provided as a Source Data ﬁle. All other data are available from the corresponding author
on reasonable request
Received: 2 May 2019; Accepted: 11 December 2019;
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